This article examines research linking an epithelial chemokine signature to treatment-linked remission patterns in inflammatory bowel disease, guiding readers toward a disease-specific biomarker-focused study.
Key Takeaways
- CXCL1 expression normalized in remission but remained elevated in non-remission patients
- Epithelial CXCL1 expression was not associated with clinical remission in Crohn’s disease
- Since epithelial barrier integrity and mucosal healing are essential for sustained remission